Yes...Jeff Lau is the CEO of BlackSwan. Here are two quotes from yesterday's PR:
"We see this as an opportunity to develop a quality product and reduce the time to market for the Delivery Pen and Supplement markets with targeted formulas we can brand and sell," said BlackSwan CEO, Jeff Lau. "Moreover, we think there's significant opportunity in this space to differentiate, capture market share and truly offer products that might help alleviate specific ailments or side effects as defined by cannabis users and we're excited to be working with the foremost authority on the subject in MyDx."
"This is a topic that many people aren't talking about because it's a bit taboo, there's big money involved and there's immense pressure to perform when injured," said BlackSwan CEO, Jeff Lau. "Fortunately, the chemicals in cannabis have shown tremendous promise in its ability to alleviate pain and inflammation in much of the same way as opioids, but without the propensity for addiction, and with the potential for additional health benefits, which are still undergoing studies."
